Showing results (131-140 of 339) with videos related to

Sort By:
Pageof 34
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Potential clinical impact of predictive modeling of heterogeneous treatment effects: scoping review of the impact of the PATH StatementJoe V Selby, Carolien C H M Maas, Bruce H Fireman, et al.
Stroke|May 7, 2026
National Evaluation of Racial, Ethnic, and Insurance-Based Disparities in Interhospital Transfer of Patients With Ischemic StrokeAshby Clay Turner, Shen Li, Feras Wahab, et al.
Transplantation Direct|November 6, 2023
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart TransplantationWhitney A Perry, Jennifer K Chow, Jason Nelson, et al.
Stroke|April 17, 2004
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?David M Kent, Judith Hinchey, Lori Lyn Price, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Epidemiology|November 29, 2025
Diverging conclusions from risk difference and difference in restricted mean survival time in quantifying absolute treatment effect heterogeneityCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
The American Journal of Bioethics : AJOB|November 26, 2003
Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchersDavid M Kent, Makaya Mwamburi, Richard A Cash, et al.
AIDS Patient Care and Stds|April 10, 2015
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on StatinsMartin Krsak, David M Kent, Norma Terrin, et al.
BMC Medical Research Methodology|March 28, 2023
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approachesAlexandros Rekkas, Peter R Rijnbeek, David M Kent, et al.
Stroke|December 1, 2004
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trialsDavid M Kent, Lori Lyn Price, Peter Ringleb, et al.
Pageof 34